- Home
- KMDA vs MIY Comparison
KMDA vs MIY Comparison
Compare KMDA & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- MIY
- Stock Information
- Founded
- KMDA 1990
- MIY 1992
- Country
- KMDA Israel
- MIY United States
- Employees
- KMDA N/A
- MIY N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- MIY Investment Bankers/Brokers/Service
- Sector
- KMDA Health Care
- MIY Finance
- Exchange
- KMDA Nasdaq
- MIY Nasdaq
- Market Cap
- KMDA 380.7M
- MIY 324.7M
- IPO Year
- KMDA N/A
- MIY N/A
- Fundamental
- Price
- KMDA $6.89
- MIY $11.58
- Analyst Decision
- KMDA Strong Buy
- MIY
- Analyst Count
- KMDA 3
- MIY 0
- Target Price
- KMDA $14.67
- MIY N/A
- AVG Volume (30 Days)
- KMDA 53.8K
- MIY 56.8K
- Earning Date
- KMDA 05-14-2025
- MIY 01-01-0001
- Dividend Yield
- KMDA 2.89%
- MIY 3.98%
- EPS Growth
- KMDA 66.67
- MIY N/A
- EPS
- KMDA 0.25
- MIY N/A
- Revenue
- KMDA $160,953,000.00
- MIY N/A
- Revenue This Year
- KMDA $14.01
- MIY N/A
- Revenue Next Year
- KMDA $9.24
- MIY N/A
- P/E Ratio
- KMDA $27.37
- MIY N/A
- Revenue Growth
- KMDA 12.93
- MIY N/A
- 52 Week Low
- KMDA $4.74
- MIY $9.45
- 52 Week High
- KMDA $9.15
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- KMDA 58.32
- MIY 59.88
- Support Level
- KMDA $6.69
- MIY $11.39
- Resistance Level
- KMDA $7.10
- MIY $11.76
- Average True Range (ATR)
- KMDA 0.16
- MIY 0.15
- MACD
- KMDA 0.05
- MIY 0.04
- Stochastic Oscillator
- KMDA 72.00
- MIY 72.31
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.